Warning : Yaz, Yasmin, Ocella, and BeYaz can cause DVT (Deep Vein Thrombosis, Pulmonary Embolism, Stroke, Heart Attack, Blood Clots, and Death
- Cigarette smoking increases the risk of serious cardiovascular events
- Cardiovascular events increase in women over 35
Stop using Yaz, Yasmin, Ocella, and/or BeYaz and call your health care provider if you have any of the following side effects:
- Sudden numbness
- Pain behind your eyes
- Problems with vision
- Problems with speech
- Problems with balance
- Chest pain
- Pain spreading to your arms
- Migraines Headaches
On April 11 2012, the FDA (Food and Drug Administration) order Bayer (The manufacturer of yaz & yasmin) to provide stronger and more clear warnings on their packaging labels of yaz and yasmin blood-clot dangers.
The new labels will include the below information:
“Vascular risks: Stop Yaz if a thrombotic event occurs. Stop at least 4 weeks before and through 2 weeks after major surgery. Start no earlier than 4 weeks after delivery, in women who are not breastfeeding. (5.1) COCs containing DRSP may be associated with a higher risk of venous thromboembolism (VTE) than COCs containing levonorgestrel or some other progestins. Before initiating Yaz in a new COC user or a woman who is switching from a contraceptive that does not contain DRSP, consider the risks and benefits of a DRSP-containing COC in light of her risk of a VTE. (5.1)”
You have the right to trust your medication is safe. Tragically, this is not always the case. Well versed in the product liability laws that protect consumers, our court appointed Yaz, Yasmin, Ocella and BeYaz MDL (Multi-district Litigation) attorney are here to help. We represent you, we do not represent drug manufacturers or insurance companies. We invite you to contact The Maher Law Firm or Frank Eidson Attorney At Law today.